This week has been a fascinating firestorm for me. Part of the excitement came after a series of tweets I published about some of the concerns I have as psychedelic medicine makes the leap from research to for-profit startups and companies. Here is what I wrote:
Rick Doblin — The Psychedelic Domino That Tips All Others (#440)
Rick Doblin, PhD, (@rickdoblin) is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS). He received his doctorate in public policy from Harvard’s Kennedy School of Government, where he wrote his dissertation on the regulation of the medical uses of psychedelics and marijuana and his master’s thesis on a survey of …
Continue reading “Rick Doblin — The Psychedelic Domino That Tips All Others (#440)”